In-hospital costs associated with chronic constipation in Belgium: A retrospective database study

Neurogastroenterology and Motility

Volumn 26, Issue 3, 2014, Pages 368-376

  Chevalier, P ^a   Lamotte, M ^a   Joseph, A ^b   Dubois, D ^c   Boeckxstaens, G ^d  

^a IQVIA   (United States)

^b Shire   (Switzerland)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^d UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Chronic constipation; Costs; Drug use; Economic burden

Indexed keywords

CHRONIC CONSTIPATION; COSTS; DRUG USE; ECONOMIC BURDEN;

ADULT; AGED; BELGIUM; CHRONIC DISEASE; CONSTIPATION; DATABASES, FACTUAL; FEMALE; HOSPITAL COSTS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84894242774     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/nmo.12269     Document Type: Article

References (17)

1. Peppas G, Alexiou V, Mourtzoukou E, Falagas M. Epidemiology of constipation in Europe and Oceania: a systematic review. BMC Gastroenterology 2008; 8: 5.
2. Belsey J, Greenfield S, Candy D, Geraint M. Systematic review: impact of constipation on quality of life in adults and children. Aliment Pharmacol Ther 2010; 31: 938-49.
3. Chang JY, Locke GR 3rd, McNally MA, Halder SL, Schleck CD, Zinsmeister AR, Talley NJ. Impact of functional gastrointestinal disorders on survival in the community. Am J Gastroenterol 2010; 105: 822-32.
4. Thompson G. The road to Rome. Gastroenterology 2006; 130: 1552-6.
5. Rome III diagnostic criteria for functional gastrointestinal disorders. 2006. Available at: http://www.romecriteria.org/assets/pdf/19_RomeIII_apA_885-898.pdf.
6. Longstreth G, Thompson G, Chey W, Houghton L, Mearin F, Spiller R. Functional bowel disorders. Gastroenterology 2006; 130: 1480-91.
7. Talley NJ, Jones M, Nuyts G, Dubois D. Risk factors for chronic constipation based on a general practice sample. Am J Gastroenterol 2003; 98: 1107-11.
8. Panchal SJ, Müller-Schwefe P, Wurzelmann JI. Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden. Int J Clin Pract 2007; 61: 1181-7.
9. De Hert M, Hudyana H, Dockx L, Bernagie C, Sweers K, Tack J, Leucht S, Peuskens J. Second-generation antipsychotics and constipation: a review of the literature. Eur Psychiatry 2011; 26: 34-44.
10. De Hert M, Dockx L, Bernagie C, Peuskens B, Sweers K, Leucht S, Tack J, Van de Straete S et al. Prevalence and severity of antipsychotic related constipation in patients with schizophrenia: a retrospective descriptive study. BMC Gastroenterol 2011; 11: 17.
11. Wald A, Scarpignato C, Mueller-Lissner S, Kamm MA, Hinkel U, Helfrich I, Schuijt C, Mandel KG. A multinational survey of prevalence and patterns of laxative use among adults with self-defined constipation. Aliment Pharmacol Ther 2008; 28: 917-30.
12. Tack J, Müller-Lissner S, Stanghellini V, Boeckxstaens G, Kamm MA, Simren M, Galmiche JP, Fried M. Diagnosis and treatment of chronic constipation - a European perspective. Neurogastroenterol Motil 2011; 23: 697-710.
13. SPF Santé Publique. Cellule Technique de traitement de données relatives aux hôpitaux. Banque Nationale de Données Diagnostic médical/soins et coût. 2011. Available at: https://tct.fgov.be/webetct/etct-web/html/fr/index.jsp.
14. Mitra D, Davis KL, Baran RW. Health care utilization and costs associated with constipation (C-ONLY) and co-occurring irritable bowel syndrome with constipation (IBS+C) compared to migraine in a large managed care population. Value Health 2007; 10: A148-9.
15. Choung RS, Branda ME, Chitkara D, Shah ND, Katusic SK, Locke GR 3rd, Talley NJ. Longitudinal direct medical costs associated with constipation in women. Aliment Pharmacol Ther 2011; 33: 251-60.
16. DaCosta DiBonaventura M, Prior M, Prieto P, Fortea J. Burden of constipation-predominant irritable bowel syndrome (IBS-C) in France, Italy and the United Kingdom. Clin Exp Gastroenterol 2012; 5: 203-12.
17. Caekelbergh K, Lamotte M, Van Megen Y. Management of opioid-induced constipation (OIC) in patients: a cost of illness study in Belgium and the Netherlands. Value Health 2009; 12: A347.